Management of adults with type 1 diabetes who are fasting before a procedure
All patients with type 1 diabetes who are fasting before a procedure should be given written instructions (including emergency contact numbers) to guide insulin management and blood glucose and ketone concentration monitoring. General principles of management are given in Instructions for patients with type 1 diabetes who are fasting before a procedure.
Insulin management [NB1] |
Continue basal insulin (either long-acting basal insulin or basal rate of rapid-acting insulin by CSII pump). Omit mealtime rapid- or short-acting bolus insulin while fasting. |
BGC monitoring |
Measure hourly from waking or from the time of the first missed meal. Measure more frequently if results are outside the target range. Target range is usually 5 to 10 mmol/L, or higher if the patient has hypoglycaemia unawareness. |
Hyperglycaemia management |
If BGC is high (more than 12 mmol/L), give a supplemental (correction) dose of rapid-acting insulin. Wait at least 4 hours before giving a further supplemental dose to avoid insulin stacking and subsequent hypoglycaemia [NB2]. If BGCs remain high, or if feeling unwell, check blood ketone concentration and follow the written instructions or seek medical assistance [NB3]. |
Hypoglycaemia management |
For hypoglycaemia when fasting for a procedure (BGC less than 5 mmol/L):
If repeated episodes of hypoglycaemia or persistent hypoglycaemia occur with developing ketosis, seek urgent medical assistance. |
Hydration maintenance |
Drink water while oral fluids are allowed. Do not drink glucose-containing fluids (eg clear apple juice) unless needed to treat hypoglycaemia. If intravenous fluid is given before a procedure, glucose-containing solution should only be given for hypoglycaemia or for management of developing ketosis (when given by intravenous infusion with extra insulin to clear ketones). |
Note:
BGC = blood glucose concentration; CSII = continuous subcutaneous insulin infusion NB1: See Suggested subcutaneous insulin management on the day of a procedure for adults with type 1 diabetes for subcutaneous insulin dose adjustments on the day of the procedure. NB2: See Supplemental (correction) insulin doses for information about calculating supplemental doses. NB3: Patients who are fasting before a procedure should be given written instructions (including emergency contact numbers) to guide BGC monitoring and insulin management. |
Adults with type 1 diabetes are occasionally prescribed adjunctive off-label treatment with metformin or sodium-glucose co-transporter 2 (SGLT2) inhibitors by specialists. SGLT2 inhibitors can cause significant adverse effects in patients who are fasting or unwell; see information about SGLT2 inhibitors and diabetic ketoacidosis (DKA) in periprocedural use of SGLT2 inhibitors.
Patients who are fasting before a procedure are at risk of hypoglycaemia and should not drive.